Japanese researchers initiated Phase I human trials of a tooth-regrowing drug, TRG-035, at Kyoto University Hospital in October 2024, targeting USAG-1 protein inhibition. With 30 participants, the trials aim for commercial readiness by 2030. While promising, experts caution that significant challenges remain before widespread availability.
Warner Music Group settled its copyright lawsuit against Suno, marking the first major label partnership with the AI company, which has secured $250 million in funding. Meanwhile, Universal Music Group and Sony Music continue litigation against Suno for alleged copyright infringement, raising discussions on the future of AI in music.
KEY POINTS:
• China's first atomic quantum computer, Hanyuan-1, has entered commercial use with orders exceeding 40 million yuan ($5.6 million), according to the South...
On September 22, 2025, the FDA announced changes to acetaminophen labeling due to links between prenatal use and neurodevelopmental disorders. While some studies suggest potential risks, major organizations like ACOG maintain it’s safe for pregnancy. Ongoing debate exists, with differing research results and calls for individualized medical guidance.
KEY POINTS:
According to the James Dyson Award project page, Project REBIRTH is "the first AI-powered crash survival system" that "deploys smart airbags, impact-absorbing...
KEY POINTS:
Two 20-something men rushed into burning home after hearing screams, according to WTHR
Guy Tarlton, 56, was trapped after falling asleep while...
KEY POINTS:
Nigeria has shifted approximately $35.5 billion worth of reserves, according to phiwallet.com on May 31, 2024
Ghana and Cameroon follow with $9.9...
KEY POINTS:
Graham Linehan arrested by five armed officers at Heathrow Airport over social media posts about transgender people
US State Department calls arrest...
